Free Trial

175,000 Shares in Anteris Technologies Global Corp (NASDAQ:AVR) Acquired by MASO CAPITAL PARTNERS Ltd

Anteris Technologies Global logo with Medical background

MASO CAPITAL PARTNERS Ltd bought a new position in shares of Anteris Technologies Global Corp (NASDAQ:AVR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 175,000 shares of the company's stock, valued at approximately $976,000. Anteris Technologies Global accounts for 1.2% of MASO CAPITAL PARTNERS Ltd's holdings, making the stock its 11th biggest holding. MASO CAPITAL PARTNERS Ltd owned about 0.49% of Anteris Technologies Global as of its most recent filing with the Securities and Exchange Commission (SEC).

Anteris Technologies Global Stock Performance

NASDAQ:AVR traded down $0.16 during mid-day trading on Monday, reaching $3.64. The stock had a trading volume of 86,437 shares, compared to its average volume of 181,195. The business has a 50 day simple moving average of $6.66. Anteris Technologies Global Corp has a 1-year low of $3.50 and a 1-year high of $8.79.

Analyst Ratings Changes

Several brokerages recently weighed in on AVR. Lake Street Capital assumed coverage on Anteris Technologies Global in a research report on Wednesday, January 8th. They issued a "buy" rating and a $20.00 target price on the stock. Cantor Fitzgerald started coverage on shares of Anteris Technologies Global in a research report on Tuesday, January 7th. They set an "overweight" rating and a $9.00 target price on the stock. Barclays started coverage on shares of Anteris Technologies Global in a report on Tuesday, January 7th. They set an "overweight" rating and a $22.00 price target for the company. Finally, TD Cowen initiated coverage on shares of Anteris Technologies Global in a report on Tuesday, January 7th. They issued a "buy" rating and a $15.00 price objective on the stock.

Check Out Our Latest Stock Analysis on Anteris Technologies Global

Anteris Technologies Global Company Profile

(Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Further Reading

Institutional Ownership by Quarter for Anteris Technologies Global (NASDAQ:AVR)

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines